A Pharmacokinetic Study of Bortezomib in Taiwanese Participants With Multiple Myeloma
Clinical trial NCT02268890 · COMPLETED
Trial details
- NCT number
- NCT02268890
- Sponsor
- Johnson & Johnson Taiwan Ltd
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2015-07-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.